GlassScriptPhysician profile
Alyson A Melin
NPI 1326347923
$4,366.22
in general payments reported to CMS, 2019-2025
22 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $1,483 · 2021: $374 · 2022: $368 · 2023: $395 · 2024: $720 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480 · Entertainment: $15.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.02 |
| Entertainment | $15.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,292.44 | 2020-2023 | |
| Allergan, INC. | $955.07 | 2019-2022 | |
| Mentor Worldwide LLC | $785.18 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $466.27 | 2021-2025 | |
| Smith+Nephew, INC. | $150.20 | 2024-2025 | Collagenase Santyl, Stravix Pl, Oasis |
| Lifenet Health | $142.86 | 2023 | |
| Avanos Medical | $89.97 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $52.65 | 2020-2021 | |
| Leo Pharma INC. | $49.49 | 2020-2022 | |
| Biocomposites INC | $47.43 | 2023 | Stimulan |
| Misonix INC | $45.80 | 2021 | |
| Integra Lifesciences Corporation | $44.18 | 2021-2024 | Integra, Omnigraft, Surgimend |
| Stryker Corporation | $37.79 | 2022 | |
| Tela Bio, INC. | $37.04 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sientra, INC. | $36.82 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $24.89 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $24.42 | 2020 | |
| Kci USA, INC. | $23.07 | 2023 | Activ.A.C. Ion Progress, Prevena Restor Bellaform |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.49 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.71 | 2022 | |
| Galderma Laboratories, L.P. | $14.16 | 2021 | |
| Biofrontera INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyson Melin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.